StockWatch
·
Pharmaceuticals
Corporate Governance4 Nov 2026, 03:12 pm

Alembic Pharma Updates Authorized Persons for Disclosures

AI Summary

Alembic Pharmaceuticals Ltd. has updated the contact details of individuals authorized to determine the materiality of events and make disclosures to stock exchanges, as per SEBI (LODR) Regulations, 2015. This update, approved by the Board of Directors on November 4, 2026, designates the Executive Chairman, two Managing Directors, the Chief Financial Officer, and the Company Secretary as the authorized personnel. Their contact details have been provided to the stock exchanges for record.

Key Highlights

  • Updated list of authorized personnel for disclosures.
  • Includes Executive Chairman, MDs, CFO, and Company Secretary.
  • Effective from November 4, 2026.
  • Compliance with SEBI (LODR) Regulations, 2015.